These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 19725893)

  • 41. [Two out-of-the-ordinary (?) case reports an asthmatic disease].
    Hausen T
    Pneumologie; 2000 Mar; 54(3):116-22. PubMed ID: 10783651
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A case of recurrent acute haemorrhagic cystitis associated with salbutamol and beclomethasone use in a paediatric patient.
    Radice S; Carnovale C; Antoniazzi S; Zuccotti G; Perrone V; Piazza A; Clementi E
    J Paediatr Child Health; 2012 Jul; 48(7):620-1. PubMed ID: 22758901
    [No Abstract]   [Full Text] [Related]  

  • 43. What's new: newly approved drugs for children.
    Abbott MB; Levin RH
    Pediatr Rev; 2001 Oct; 22(10):357-9. PubMed ID: 11581490
    [No Abstract]   [Full Text] [Related]  

  • 44. Daily use of salmeterol causes tolerance to bronchodilation with terbutaline in asthmatic subjects.
    Elers J; Strandbygaard U; Pedersen L; Backer V
    Open Respir Med J; 2010 Apr; 4():48-50. PubMed ID: 20556208
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Daily salbutamol in young patients with SMA type II.
    Pane M; Staccioli S; Messina S; D'Amico A; Pelliccioni M; Mazzone ES; Cuttini M; Alfieri P; Battini R; Main M; Muntoni F; Bertini E; Villanova M; Mercuri E
    Neuromuscul Disord; 2008 Jul; 18(7):536-40. PubMed ID: 18579379
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Salmeterol and fluticasone in young children with multiple-trigger wheeze.
    Mäkelä MJ; Malmberg LP; Csonka P; Klemola T; Kajosaari M; Pelkonen AS
    Ann Allergy Asthma Immunol; 2012 Jul; 109(1):65-70. PubMed ID: 22727160
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Best step-up treatments for children with uncontrolled asthma: a systematic review and network meta-analysis of individual participant data.
    Cividini S; Sinha I; Donegan S; Maden M; Rose K; Fulton O; Culeddu G; Hughes DA; Turner S; Tudur Smith C;
    Eur Respir J; 2023 Dec; 62(6):. PubMed ID: 37945034
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A comparison of tiotropium, long-acting β
    Vogelberg C; Goldstein S; Graham L; Kaplan A; de la Hoz A; Hamelmann E
    Respir Res; 2020 Jan; 21(1):19. PubMed ID: 31931792
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The evidence on tiotropium bromide in asthma: from the rationale to the bedside.
    Radovanovic D; Santus P; Blasi F; Mantero M
    Multidiscip Respir Med; 2017; 12():12. PubMed ID: 28484598
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Addition of long-acting beta2-agonists to inhaled corticosteroids for chronic asthma in children.
    Chauhan BF; Chartrand C; Ni Chroinin M; Milan SJ; Ducharme FM
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD007949. PubMed ID: 26594816
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Newer therapeutic agents for asthma.
    Deykin A; Israel E
    Dis Mon; 1999 Apr; 45(4):117-44. PubMed ID: 10212622
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Childhood evaluation of salmeterol tolerance--a double-blind randomized controlled trial.
    Carroll WD; Jones PW; Boit P; Clayton S; Cliff I; Lenney W
    Pediatr Allergy Immunol; 2010 Mar; 21(2 Pt 1):336-44. PubMed ID: 19725893
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Pearlman DS; Stricker W; Weinstein S; Gross G; Chervinsky P; Woodring A; Prillaman B; Shah T
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
    Murray J; Rosenthal R; Somerville L; Blake K; House K; Baitinger L; VanderMeer A; Dorinsky P
    Ann Allergy Asthma Immunol; 2004 Oct; 93(4):351-9. PubMed ID: 15521371
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
    Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
    Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.